 The objective of this study was to investigate the appropriate dosing interval of a probiotic ( Infloran) given daily , biweekly and weekly in preterm infants < 32 weeks ' gestation. There were 8 infants in the daily group , 8 infants in the biweekly group and 10 infants in the weekly group , all born between 25 and 32 weeks ' gestation. The control group consisted of 12 preterm infants who did not receive the probiotic. Infloran ( 250 mg/capsule) , containing After administration of the probiotic at 31 weeks PMA , Our results indicate that a daily dose of Infloran is a suitable dosage for preterm infants in the neonatal intensive care unit , with significantly higher levels of